These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2070 related articles for article (PubMed ID: 19505431)
21. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance. Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230 [TBL] [Abstract][Full Text] [Related]
22. Association of circulating tumor cells with tumor-related methylated DNA in patients with hormone-refractory prostate cancer. Okegawa T; Nutahara K; Higashihara E Int J Urol; 2010 May; 17(5):466-75. PubMed ID: 20337729 [TBL] [Abstract][Full Text] [Related]
23. Methylation-specific sequencing of GSTP1 gene promoter in circulating/extracellular DNA from blood and urine of healthy donors and prostate cancer patients. Bryzgunova OE; Morozkin ES; Yarmoschuk SV; Vlassov VV; Laktionov PP Ann N Y Acad Sci; 2008 Aug; 1137():222-5. PubMed ID: 18837951 [TBL] [Abstract][Full Text] [Related]
24. Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis. Cottrell S; Jung K; Kristiansen G; Eltze E; Semjonow A; Ittmann M; Hartmann A; Stamey T; Haefliger C; Weiss G J Urol; 2007 May; 177(5):1753-8. PubMed ID: 17437806 [TBL] [Abstract][Full Text] [Related]
25. Investigation of genomic methylation status using methylation-specific and bisulfite sequencing polymerase chain reaction. Carless M Methods Mol Biol; 2009; 523():217-34. PubMed ID: 19381936 [TBL] [Abstract][Full Text] [Related]
27. Bisulfite methylation analysis of tumor suppressor genes in prostate cancer from fresh and archival tissue samples. Clark SJ; Millar DS; Molloy P Methods Mol Med; 2003; 81():219-40. PubMed ID: 12725123 [No Abstract] [Full Text] [Related]
28. DNA methylation analysis by bisulfite conversion, cloning, and sequencing of individual clones. Zhang Y; Rohde C; Tierling S; Stamerjohanns H; Reinhardt R; Walter J; Jeltsch A Methods Mol Biol; 2009; 507():177-87. PubMed ID: 18987815 [TBL] [Abstract][Full Text] [Related]
29. Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells. Arapshian A; Kuppumbatti YS; Mira-y-Lopez R Oncogene; 2000 Aug; 19(35):4066-70. PubMed ID: 10962564 [TBL] [Abstract][Full Text] [Related]
30. Large fragment Bst DNA polymerase for whole genome amplification of DNA from formalin-fixed paraffin-embedded tissues. Aviel-Ronen S; Qi Zhu C; Coe BP; Liu N; Watson SK; Lam WL; Tsao MS BMC Genomics; 2006 Dec; 7():312. PubMed ID: 17156491 [TBL] [Abstract][Full Text] [Related]
31. Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens. Furusato B; Shaheduzzaman S; Petrovics G; Dobi A; Seifert M; Ravindranath L; Nau ME; Werner T; Vahey M; McLeod DG; Srivastava S; Sesterhenn IA Prostate Cancer Prostatic Dis; 2008; 11(2):194-7. PubMed ID: 17768422 [TBL] [Abstract][Full Text] [Related]
32. Profiling DNA methylation from small amounts of genomic DNA starting material: efficient sodium bisulfite conversion and subsequent whole-genome amplification. Mill J; Petronis A Methods Mol Biol; 2009; 507():371-81. PubMed ID: 18987828 [TBL] [Abstract][Full Text] [Related]
33. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance. Reibenwein J; Pils D; Horak P; Tomicek B; Goldner G; Worel N; Elandt K; Krainer M Prostate; 2007 Mar; 67(4):427-32. PubMed ID: 17192910 [TBL] [Abstract][Full Text] [Related]
34. The emerging roles of DNA methylation in the clinical management of prostate cancer. Perry AS; Foley R; Woodson K; Lawler M Endocr Relat Cancer; 2006 Jun; 13(2):357-77. PubMed ID: 16728568 [TBL] [Abstract][Full Text] [Related]
35. 5' CpG island methylation analysis identifies the MAGE-A1 and MAGE-A3 genes as potential markers of HCC. Qiu G; Fang J; He Y Clin Biochem; 2006 Mar; 39(3):259-66. PubMed ID: 16516880 [TBL] [Abstract][Full Text] [Related]
36. Methylation analysis of BRCA1, RASSF1, GSTP1 and EPHB2 promoters in prostate biopsies according to different degrees of malignancy. Rabiau N; Thiam MO; Satih S; Guy L; Kemeny JL; Boiteux JP; Fontana L; Bignon YJ; Bernard-Gallon D In Vivo; 2009; 23(3):387-91. PubMed ID: 19454503 [TBL] [Abstract][Full Text] [Related]
37. Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer. Millar DS; Ow KK; Paul CL; Russell PJ; Molloy PL; Clark SJ Oncogene; 1999 Feb; 18(6):1313-24. PubMed ID: 10022813 [TBL] [Abstract][Full Text] [Related]
38. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects. Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165 [TBL] [Abstract][Full Text] [Related]